Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Down0.12% Nasdaq Down0.07%

Galectin Therapeutics, Inc. (GALT)

-NasdaqCM

4.42 Up 0.02(0.45%) 3:59PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 30, 2012Dec 30, 2011Dec 30, 2010
Total Revenue -   -   -  
Cost of Revenue -   -   -  
Gross Profit -   -   -  
Operating Expenses
Research Development4,527  3,552  1,066  
Selling General and Administrative5,372  6,857  3,817  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (9,899) (10,409) (4,883)
Income from Continuing Operations
Total Other Income/Expenses Net224  (506)(746)
Earnings Before Interest And Taxes(9,675)(10,915)(5,629)
Interest Expense -   -   -  
Income Before Tax(9,675)(10,915)(5,629)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(9,675)(10,915)(5,629)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (9,675) (10,915) (5,629)
Preferred Stock And Other Adjustments(1,206)(1,798)(3,080)
Net Income Applicable To Common Shares (10,881) (12,713) (8,709)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.